| Published Application/Species/Sample/Dilution | Reference | 
|---|
| western blot knockout validation; human; loading ...; fig 1b
 | Sivakumar S, Qi S, Cheng N, Sathe A, Kanchwala M, Kumar A, et al . TP53 promotes lineage commitment of human embryonic stem cells through ciliogenesis and sonic hedgehog signaling. Cell Rep. 2022;38:110395 pubmed  publisher | 
| western blot; rat; 1:200; loading ...; fig 3c
 | Cai H, Han B, Hu Y, Zhao X, He Z, Chen X, et al . Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways. Int J Mol Med. 2020;45:715-730 pubmed  publisher | 
| western blot; mouse; 1:200; loading ...; fig s5b
 | Goodman D, Pretto C, Krepostman T, Carnahan K, Spindler K. Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR). MBio. 2019;10: pubmed  publisher | 
| western blot; mouse; 1:1000; loading ...; fig 7a
 | Li R, Sahu S, Schachner M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor Neurol Neurosci. 2018;36:469-483 pubmed  publisher | 
| western blot; human; 1:3000; loading ...; fig 1d
 | Liu W, Huang K, Lu M, Huang H, Chen C, Cheng Y, et al . TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability. Oncogene. 2017;36:2715-2723 pubmed  publisher | 
| immunoprecipitation; human; loading ...; fig 2gwestern blot; human; loading ...; fig 4a
 | Luo H, Cowen L, Yu G, Jiang W, Tang Y. SMG7 is a critical regulator of p53 stability and function in DNA damage stress response. Cell Discov. 2016;2:15042 pubmed  publisher | 
| immunohistochemistry - paraffin section; mouse; fig 6
 | Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed  publisher | 
| western blot; human; fig 2
 | Katoh I, Fukunishi N, Fujimuro M, Kasai H, Moriishi K, Hata R, et al . Repression of Wnt/β-catenin response elements by p63 (TP63). Cell Cycle. 2016;15:699-710 pubmed  publisher | 
| western blot; human; fig 1a
 | Du C, Wu H, Leng R. UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation. Oncotarget. 2016;7:2823-36 pubmed  publisher | 
| western blot; human; 1:500; fig 6
 | Vétillard A, Jonchère B, Moreau M, Toutain B, Henry C, Fontanel S, et al . Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis. Oncotarget. 2015;6:43342-62 pubmed  publisher | 
| western blot; mouse; fig 3western blot; human; fig 3
 | Crivellaro S, Panuzzo C, Carrà G, Volpengo A, Crasto F, Gottardi E, et al . Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion. Oncotarget. 2015;6:25217-25 pubmed  publisher | 
| immunocytochemistry; human
 | Bishop R, Valle Oseguera C, Spencer J. Human Cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells. Cancer Cell Microenviron. 2015;2: pubmed | 
| western blot; human; 1:500; fig 3
 | Mahale S, Bharate S, Manda S, Joshi P, Jenkins P, Vishwakarma R, et al . Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. Cell Death Dis. 2015;6:e1743 pubmed  publisher | 
| chromatin immunoprecipitation; human; fig 3bwestern blot; human; fig 1f
 | Wang X, Docanto M, Sasano H, Lo C, Simpson E, Brown K. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer. Cancer Res. 2015;75:645-55 pubmed  publisher | 
|  | Weilbacher A, Gutekunst M, Oren M, Aulitzky W, van der Kuip H. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38. Cell Death Dis. 2014;5:e1318 pubmed  publisher | 
|  | Mukherjee S, Maddalena M, Lu Y, Martinez S, Nataraj N, Noronha A, et al . Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins. Proc Natl Acad Sci U S A. 2022;119:e2119644119 pubmed  publisher | 
|  | Miller J, Dakic A, Spurgeon M, Saenz F, Kallakury B, Zhao B, et al . AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression. J Med Virol. 2022;94:3962-3977 pubmed  publisher | 
|  | Chang C, Kuo C, Ito T, Su Y, Jiang S, Chiu M, et al . CK1? ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. Proc Natl Acad Sci U S A. 2017;114:E8035-E8044 pubmed  publisher | 
|  | Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov V, et al . Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. J Biol Chem. 2017;292:15340-15351 pubmed  publisher | 
|  | Min J, Wright W, Shay J. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes. Mol Cell Biol. 2017;37: pubmed  publisher | 
|  | Min M, Chen X, Wang P, Landeck L, Chen J, Li W, et al . Role of keratin 24 in human epidermal keratinocytes. PLoS ONE. 2017;12:e0174626 pubmed  publisher | 
|  | Yao C, Chow J, Lin P, Hu T, Kuo H, Huang J, et al . Activation of p53/miR-34a Tumor Suppressor Axis by Chinese Herbal Formula JP-1 in A549 Lung Adenocarcinoma Cells. Evid Based Complement Alternat Med. 2016;2016:5989681 pubmed  publisher | 
|  | Vaughan C, Pearsall I, Singh S, Windle B, Deb S, Grossman S, et al . Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter. Oncotarget. 2016;7:12426-46 pubmed  publisher | 
|  | Chand H, Montaño G, Huang X, Randell S, Mebratu Y, Petersen H, et al . A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression. Nat Commun. 2014;5:5567 pubmed  publisher | 
|  | Huang Y, Bulavin D. Oncogene-mediated regulation of p53 ISGylation and functions. Oncotarget. 2014;5:5808-18 pubmed | 
|  | Bassères D, Ebbs A, Cogswell P, Baldwin A. IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity. Genes Cancer. 2014;5:41-55 pubmed | 
|  | Loughery J, Cox M, Smith L, Meek D. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acids Res. 2014;42:7666-80 pubmed  publisher | 
|  | Tengku Ahmad T, Jaafar F, Jubri Z, Abdul Rahim K, Rajab N, Makpol S. Gelam honey attenuated radiation-induced cell death in human diploid fibroblasts by promoting cell cycle progression and inhibiting apoptosis. BMC Complement Altern Med. 2014;14:108 pubmed  publisher | 
|  | Contreras A, Mebratu Y, Delgado M, Montaño G, Hu C, Ryter S, et al . Deacetylation of p53 induces autophagy by suppressing Bmf expression. J Cell Biol. 2013;201:427-37 pubmed  publisher | 
|  | Cai B, Hsu P, Hsin I, Chao C, Lu M, Lin H, et al . p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation. PLoS ONE. 2012;7:e41742 pubmed  publisher | 
|  | Thomas M, Luchelli L, Pascual M, Gottifredi V, Boccaccio G. A monoclonal antibody against p53 cross-reacts with processing bodies. PLoS ONE. 2012;7:e36447 pubmed  publisher | 
|  | Rahman M, Zhang Z, Mody A, Su D, Das H. Intraperitoneal injection of JNK-specific inhibitor SP600125 inhibits the expression of presenilin-1 and Notch signaling in mouse brain without induction of apoptosis. Brain Res. 2012;1448:117-28 pubmed  publisher | 
|  | Bansal N, Kadamb R, Mittal S, Vig L, Sharma R, Dwarakanath B, et al . Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress. PLoS ONE. 2011;6:e26156 pubmed  publisher | 
|  | Lenos K, de Lange J, Teunisse A, Lodder K, Verlaan de Vries M, Wiercinska E, et al . Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts. Mol Cancer. 2011;10:111 pubmed  publisher | 
|  | Goñi Oliver P, Avila J, Hernandez F. Calpain regulates N-terminal interaction of GSK-3? with 14-3-3?, p53 and PKB but not with axin. Neurochem Int. 2011;59:97-100 pubmed  publisher | 
|  | Wang X, Wang J, Jiang X. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J Biol Chem. 2011;286:23725-34 pubmed  publisher | 
|  | Meissner J, FREUND R, Krone D, Umeda P, Chang K, Gros G, et al . Extracellular signal-regulated kinase 1/2-mediated phosphorylation of p300 enhances myosin heavy chain I/beta gene expression via acetylation of nuclear factor of activated T cells c1. Nucleic Acids Res. 2011;39:5907-25 pubmed  publisher | 
|  | Midde K, Batchinsky A, Cancio L, Shetty S, Komissarov A, Florova G, et al . Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its mRNA in porcine lung cells. Shock. 2011;36:128-37 pubmed  publisher | 
|  | Renault V, Thekkat P, Hoang K, White J, Brady C, Kenzelmann Broz D, et al . The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene. 2011;30:3207-21 pubmed  publisher | 
|  | Liu X, Yang J, Zhang S, Liu X, Liu D. Induction of cell cycle arrest at G1 and S phases and cAMP-dependent differentiation in C6 glioma by low concentration of cycloheximide. BMC Cancer. 2010;10:684 pubmed  publisher | 
|  | Smoak K, Aloor J, Madenspacher J, Merrick B, Collins J, Zhu X, et al . Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 2010;11:493-502 pubmed  publisher | 
|  | Eby K, Rosenbluth J, Mays D, Marshall C, Barton C, Sinha S, et al . ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy. Mol Cancer. 2010;9:95 pubmed  publisher | 
|  | Aylon Y, Yabuta N, Besserglick H, Buganim Y, Rotter V, Nojima H, et al . Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene. 2009;28:4469-79 pubmed  publisher | 
|  | Kim C, Jung S, Naqvi A, Hoffman T, Dericco J, Yamamori T, et al . p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc. Circ Res. 2008;103:1441-50 pubmed  publisher | 
|  | Gochhait S, Dar S, Pal R, Gupta P, Bamezai R. Expression of DNA damage response genes indicate progressive breast tumors. Cancer Lett. 2009;273:305-11 pubmed  publisher | 
|  | Maimets T, Neganova I, Armstrong L, Lako M. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene. 2008;27:5277-87 pubmed  publisher | 
|  | Reamon Buettner S, Ciribilli Y, Inga A, Borlak J. A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Hum Mol Genet. 2008;17:1397-405 pubmed  publisher | 
|  | Saito T, Hama S, Izumi H, Yamasaki F, Kajiwara Y, Matsuura S, et al . Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells. Br J Cancer. 2008;98:345-55 pubmed  publisher | 
|  | Yosifov D, Dineva I, Zaharieva M, Konstantinov S, Berger M. The expression level of the tumor suppressor retinoblastoma protein (Rb) influences the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium (ErPC3). Cancer Biol Ther. 2007;6:930-5 pubmed | 
|  | Kennedy R, Chen C, Stuckert P, Archila E, De la Vega M, Moreau L, et al . Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest. 2007;117:1440-9 pubmed | 
|  | Jackson R, Cho Y, Stein S, Liang P. CYFIP2, a direct p53 target, is leptomycin-B sensitive. Cell Cycle. 2007;6:95-103 pubmed | 
|  | Alves da Costa C, Sunyach C, Pardossi Piquard R, Sevalle J, Vincent B, Boyer N, et al . Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci. 2006;26:6377-85 pubmed | 
|  | Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 2006;25:135-41 pubmed | 
|  | Le H, Minn A, Massague J. Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J Biol Chem. 2005;280:32018-25 pubmed | 
|  | Fan X, Liu Y, Chen J. Down-regulation of p21 contributes to apoptosis induced by HPV E6 in human mammary epithelial cells. Apoptosis. 2005;10:63-73 pubmed |